Avadel Pharmaceuticals-adr (AVDL) Live Share Price, Invest From India

Avadel Pharmaceuticals-adr Stock Performance

as on February 12, 2026 at 7:59 am IST

Day's Low
Day's High
$21.63
Day's Price Range
$21.76
$21.67
0.18%
Downside
0.42%
Upside
52 Week's Low
52 Week's High
$6.38
52-Week Price Range
$23.57
$21.67
70.56%
Downside
8.77%
Upside

Avadel Pharmaceuticals-adr share price movements today

Previous Close: $21.63
Open: $21.66
Volume: 16.1M
Day's Low - High: $21.63 - $21.76
52 Week Low - High: $6.38 - $23.57

Avadel Pharmaceuticals-adr Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Avadel Pharmaceuticals-adr Stock Fundamentals & Key Indicators

Check Avadel Pharmaceuticals-adr market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Avadel Pharmaceuticals-adr vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Avadel Pharmaceuticals-adr with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Avadel Pharmaceuticals-adr	BUY	$-	NA	NA	0.00%
Regencell Bioscience Holdings Ltd	NA	$12.5B	NA	NA	0.00%
United Therapeutics Corporation	BUY	$23.3B	NA	18.69	41.94%
Haleon Plc Spon Ads	BUY	$44.3B	NA	20.27	15.11%
Viatris Inc.	HOLD	$15.3B	-4.71%	-21.95	-24.58%

See all

Analyst Recommendation on Avadel Pharmaceuticals-adr Stock

Based on 16 analysts

BUY

93.75%

Buy

6.25%

Hold

0.00%

Sell

Based on 16 analysts, 93.75% of analysts recommend a 'BUY' rating for Avadel Pharmaceuticals-adr. Average target price of $20.94

Avadel Pharmaceuticals-adr Share Price Target

Get share price movements and forecasts by analysts on Avadel Pharmaceuticals-adr.

What analysts predicted

-3.49%DOWNSIDE

Target Price

$20.94

Current Price

$21.67

Analyzed by

16 Analysts

Target

$20.94

Avadel Pharmaceuticals-adr target price $20.94, a slight downside of -3.49% compared to current price of $21.67. According to 16 analysts rating.

Avadel Pharmaceuticals-adr Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	1	7	19	27	41	50	50	52	68	77
Gross Profit	1	6	18	25	38	43	45	46	61	80
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-64	-36	-28	-27	-13	-2	-5	-4	9	0
Net Profit Margin	-4306.95%	-517.17%	-147.98%	-100.60%	-33.30%	-5.25%	-10.00%	-9.37%	14.19%	0.03%

Avadel Pharmaceuticals-adr Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	173	150	172	103	59	22	-	1	27	169
Gross Profit	162	136	156	85	47	16	0	-1	27	153
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	40	-41	67	-95	-33	7	-77	-137	-160	-48
Net Profit Margin	23.47%	-27.47%	38.93%	-92.29%	-56.11%	31.47%	0.00%	-9188.77%	-573.17%	-28.87%

Global Institutional Holdings in Avadel Pharmaceuticals-adr

Funds	Holdings
BlackRock Inc	7.01%
Gendell Jeffrey L	5.33%
Morgan Stanley - Brokerage Accounts	1.23%
Northern Trust Corp	0.86%
Brandes Investment Partners & Co	6.68%

See all

Insights on Avadel Pharmaceuticals-adr

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, AVDL stock has moved up by 57.2%
NO EFFECT
Against Peers
In the last 3 years, Regencell Bioscience Holdings Ltd has given 3523.5% return, outperforming this stock by 3356.0%
NO EFFECT
Against Peers
In the last 1 year, Regencell Bioscience Holdings Ltd has given 28265.2% return, outperforming this stock by 28124.5%

About Avadel Pharmaceuticals-adr

Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.

Organisation	Avadel Pharmaceuticals-adr
E-voting on shares	Click here to vote

FAQs

What is Avadel Pharmaceuticals-adr share price today?

Avadel Pharmaceuticals-adr share price today is $21.67 as on February 12, 2026 at 2:29 am IST. Avadel Pharmaceuticals-adr share today touched a day high of $21.76 and a low of $21.63.

What is the 52 week high and 52 week low for Avadel Pharmaceuticals-adr share?

Avadel Pharmaceuticals-adr share touched a 52 week high of $23.57 on November 14, 2025 and a 52 week low of $6.38 on April 9, 2025. Avadel Pharmaceuticals-adr stock price today i.e. February 12, 2026 at 2:29 am IST is trending at $21.67,which is 8.06% down from its 52 week high and 239.66% up from its 52 week low.

How to invest in Avadel Pharmaceuticals-adr Stock (AVDL) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Avadel Pharmaceuticals-adr on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Avadel Pharmaceuticals-adr Shares that will get you 0.0692 shares as per Avadel Pharmaceuticals-adr share price of $21.67 per share as on February 12, 2026 at 2:29 am IST.

What is the minimum amount required to buy Avadel Pharmaceuticals-adr Stock (AVDL) from India?

Indian investors can start investing in Avadel Pharmaceuticals-adr (AVDL) shares with as little as ₹94.138 or $1 (as of March 25, 2026 at 9:13 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹941.38 in Avadel Pharmaceuticals-adr stock (as per the Rupee-Dollar exchange rate as on March 25, 2026 at 9:13 pm IST). Based on Avadel Pharmaceuticals-adr share’s latest price of $21.67 as on February 12, 2026 at 2:29 am IST, you will get 0.4615 shares of Avadel Pharmaceuticals-adr. Learn more about fractional shares .